The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis

PLoS One. 2016 Aug 11;11(8):e0161036. doi: 10.1371/journal.pone.0161036. eCollection 2016.

Abstract

Purpose: In secondary progressive Multiple Sclerosis (SPMS), global neurodegeneration as a driver of disability gains importance in comparison to focal inflammatory processes. However, clinical MRI does not visualize changes of tissue composition outside MS lesions. This quantitative MRI (qMRI) study investigated cortical and deep gray matter (GM) proton density (PD) values and T1 relaxation times to explore their potential to assess neuronal damage and its relationship to clinical disability in SPMS.

Materials and methods: 11 SPMS patients underwent quantitative T1 and PD mapping. Parameter values across the cerebral cortex and deep GM structures were compared with 11 healthy controls, and correlation with disability was investigated for regions exhibiting significant group differences.

Results: PD was increased in the whole GM, cerebral cortex, thalamus, putamen and pallidum. PD correlated with disability in the whole GM, cerebral cortex, putamen and pallidum. T1 relaxation time was prolonged and correlated with disability in the whole GM and cerebral cortex.

Conclusion: Our study suggests that the qMRI parameters GM PD (which likely indicates replacement of neural tissue with water) and cortical T1 (which reflects cortical damage including and beyond increased water content) are promising qMRI candidates for the assessment of disease status, and are related to disability in SPMS.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Case-Control Studies
  • Cerebral Cortex / diagnostic imaging
  • Cerebral Cortex / pathology*
  • Female
  • Gray Matter / diagnostic imaging
  • Gray Matter / pathology*
  • Humans
  • Intellectual Disability / diagnostic imaging
  • Intellectual Disability / pathology*
  • Magnetic Resonance Imaging / methods*
  • Male
  • Multiple Sclerosis, Chronic Progressive / diagnostic imaging
  • Multiple Sclerosis, Chronic Progressive / pathology*

Grants and funding

This work was supported by the Bundesministerium für Bildung und Forschung [DLR 01GO0203; Brain Imaging Center Frankfurt], the Deutsche Forschungsgemeinschaft [DFG CRC-TR 128; Drs Zipp and Deichmann] and the LOEWE-Program “Neuronal Coordination Forschungsschwerpunkt Frankfurt” (NeFF) [ZA 233/1-1].